Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Wasserman

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|August 1, 2021
Oral Immunotherapy-Related Awareness, Attitudes, and Experiences Among a Nationally Representative Sample of Food Allergy Patients/CaregiversChristopher M Warren, Anita Roach, Rajeshree Das, et al.
International Journal of Molecular Sciences|November 7, 2020
Microbiological, Physicochemical, and Immunological Analysis of a Commercial Cashew Nut-Based YogurtChristopher P Mattison, Kayanush J Aryana, Kristen Clermont, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 8, 2019
The real world is not standardizedRichard L Wasserman, Angela R Hague, Deanna M Pence, et al.
Advances in Therapy|October 12, 2012
Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacksMichael J Prematta, Againdra K Bewtra, Robyn J Levy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 3, 2018
Real-World Experience with Peanut Oral Immunotherapy: Lessons Learned From 270 PatientsRichard L Wasserman, Angela R Hague, Deanna M Pence, et al.
Immunotherapy|May 9, 2023
Development of a novel shared decision making aid for primary immunodeficiency diseasesSpiros Tzivelekis, Jordan Orange, Christine Poulos, et al.
Journal of Clinical Immunology|May 11, 2010
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyJohn B Hagan, Mary B Fasano, Sheldon Spector, et al.
Expert Review of Clinical Immunology|February 1, 2012
Safety of L-proline as a stabilizer for immunoglobulin productsJohn B Hagan, Richard L Wasserman, Jeffrey S Baggish, et al.
Journal of Clinical Immunology|November 12, 2018
Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 TrialsStephen Jolles, Mikhail A Rojavin, John-Philip Lawo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2006
Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled studyRichard L Wasserman, James W Baker, Kenneth T Kim, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology. in Practice|August 1, 2021
Oral Immunotherapy-Related Awareness, Attitudes, and Experiences Among a Nationally Representative Sample of Food Allergy Patients/CaregiversChristopher M Warren, Anita Roach, Rajeshree Das, et al.
International Journal of Molecular Sciences|November 7, 2020
Microbiological, Physicochemical, and Immunological Analysis of a Commercial Cashew Nut-Based YogurtChristopher P Mattison, Kayanush J Aryana, Kristen Clermont, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 8, 2019
The real world is not standardizedRichard L Wasserman, Angela R Hague, Deanna M Pence, et al.
Advances in Therapy|October 12, 2012
Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacksMichael J Prematta, Againdra K Bewtra, Robyn J Levy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 3, 2018
Real-World Experience with Peanut Oral Immunotherapy: Lessons Learned From 270 PatientsRichard L Wasserman, Angela R Hague, Deanna M Pence, et al.
Immunotherapy|May 9, 2023
Development of a novel shared decision making aid for primary immunodeficiency diseasesSpiros Tzivelekis, Jordan Orange, Christine Poulos, et al.
Journal of Clinical Immunology|May 11, 2010
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyJohn B Hagan, Mary B Fasano, Sheldon Spector, et al.
Expert Review of Clinical Immunology|February 1, 2012
Safety of L-proline as a stabilizer for immunoglobulin productsJohn B Hagan, Richard L Wasserman, Jeffrey S Baggish, et al.
Journal of Clinical Immunology|November 12, 2018
Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 TrialsStephen Jolles, Mikhail A Rojavin, John-Philip Lawo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2006
Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled studyRichard L Wasserman, James W Baker, Kenneth T Kim, et al.
Pageof 10